FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/18/2024
Back to search
Official data from USPTO
SURETACS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/18/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
04/29/2022
Registration date
11/21/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2023
Last transaction
11/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
26
Owner location
NL
Examiner
CARROLL, DORITT
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Laigo Bio B.V.
Representatives
Elizabeth A. Cominolli Markert & Cominolli PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer; drugs for medical purposesmedicinal preparations for the treatment of cancerinflammationneurodegeneration and immune disorders; pharmaceutical preparations for the treatment and the prevention of diseases and disordersanti-canceranti-inflammationanti-neurodegeneration and immunological preparations; colostral antibodies for medical purposes
Class 42
Scientific research; development of pharmaceutical preparations and medicines; medical and pharmacological research services; researchtesting and inspection of pharmaceuticals; medical and pharmacological research and development services in the field of antibodies; creation and maintenance of websites for others in the field of medical research and pharmaceuticals
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/22/2024
FIMP
FINAL DISPOSITION PROCESSED
02/22/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/26/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/26/2023
RFNT
REFUSAL PROCESSED BY IB
05/02/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/06/2023
RFRR
REFUSAL PROCESSED BY MPU
04/06/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/18/2023
CNRT
NON-FINAL ACTION WRITTEN
02/17/2023
DOCK
ASSIGNED TO EXAMINER
02/17/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/17/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/16/2022
Continuous trademark protection
Get notified about every new filing that threatens SURETACS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.